Ipca Laboratories Reports Strong Financial Results for December 2024, Highlighting Operational Efficiency
Ipca Laboratories has announced its financial results for the quarter ending December 2024, highlighting strong growth in key metrics within the pharmaceuticals sector. The company reported significant increases in operating profit, profit before tax, and profit after tax, alongside improved operating profit margins and earnings per share.
Ipca Laboratories has reported its financial results for the quarter ending December 2024, showcasing a robust performance in the pharmaceuticals and drugs sector. The company has demonstrated significant growth in key financial metrics, reflecting its strong operational capabilities.Notably, the operating profit to interest ratio reached a remarkable 27.55 times, indicating an enhanced ability to manage interest payments effectively. The profit before tax, excluding other income, stood at Rs 347.81 crore, marking a substantial increase compared to the average of the previous four quarters. Similarly, the profit after tax was reported at Rs 248.14 crore, showcasing impressive growth over the same period.
The operating profit, recorded at Rs 463.08 crore, was the highest in the last five quarters, further emphasizing the company's operational efficiency. Additionally, the operating profit margin improved to 20.62%, reflecting better cost management and productivity. The earnings per share also reached a peak of Rs 9.78, indicating a positive trend in profitability for shareholders.
Overall, Ipca Laboratories has experienced notable evaluation changes in its financial performance, reinforcing its position in the market.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
